BioSpace News Archive

Press Releases

Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy

April 4, 2025
·
7 min read
Press Releases

Elutia to Participate in Upcoming April 2025 Investor Conferences

April 4, 2025
·
1 min read
Press Releases

Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

April 4, 2025
·
1 min read
Press Releases

Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline

April 4, 2025
·
4 min read
Press Releases

Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301

April 4, 2025
·
6 min read
Press Releases

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

April 4, 2025
·
5 min read
Press Releases

Extendicare Announces Timing of 2025 First Quarter Results and Conference Call

April 4, 2025
·
1 min read
Press Releases

Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa

April 4, 2025
·
3 min read
Press Releases

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

April 4, 2025
·
16 min read
Press Releases

Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN

April 4, 2025
·
6 min read